Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma

导出原文传递

翻译打印收藏纠错

作者： Subbiah, Vivek ^[1] ; Meyer, Christian ^[2] ; Zinner, Ralph ; Meric-Bernstam, Funda ; Zahurak, Marianna L. ; O'Connor, Ashley ; Roszik, Jason ; Shaw, Kenna ; Ludwig, Joseph A. ; Kurzrock, Razelle ; Azad, Nilofer A.

作者单位： Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA ^[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA ^[2]

发布时间 2017-12-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical cancer research

2017年23卷15期

4027-4034页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除